A STUDY OF SERUM MAGNESIUM PROFILE IN TYPE – 2 DIABETES MELLITUS
Abstract
Serum hyperglycaemia resulting from defects in insulin secretion, insulin action (may be due to failure of complex insulin – receptor interaction) or both. According to the International Diabetes Federation (IDF), diabetes has affected at least 300 million people worldwide, and this number is expected to reach 450 million by the year 2030. There are mainly two types of diabetes Type–1 and Type-2, the latter type of diabetes mellitus is the most common form of diabetes accounting for 90% of the cases. In India, the scenario is not different when compared to the world scenario. The best strategies are not able to prevent the complications suggesting that alternative treatment strategies are needed. Insulin-dependent uptake of glucose is reduced in magnesium deficiency. Magnesium supplementation improves glucose tolerance. So one such treatment strategy under research is supplementation of magnesium and its role in primary prevention of diabetes and slowing the progression of complications that is related to the dreaded disease. So before anything it is best to understand the profile of serum magnesium in type 2 Diabetes mellitus. So this study is dedicated for this above said cause.
Keywords
Full Text:
PDFReferences
Khodeir SA, Abd El Raouf YM, Amer A, et al. Paraoxonase gene polymorphism and activity in type 2 diabetes mellitus with microvascular complications. Journal of American Science, 2012;8(4):531-535.
Jiancheng Xu, Qi Zhou, Gilbert Liu, et al. Analysis of serum and urinal copper and zinc in Chinese northeast population with the prediabetes or diabetes with and without complications. Oxidative Medicine and Cellular Longevity Article ID- 635214, 2013;2013:pp 11.
Prajna K, Ashok Kumar J, Srinidhi Rai, et al. Predictive value of serum sialic acid in type-2 diabetes mellitus and its complication (Nephropathy). Journal of Clinical and Diagnostic Research 2013;7(11):2435-2437.
Jeanette Schultz Johansen, Alex K Harris, David J Rychly, et al. Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice. Cardiovasc Diabetol 2005;4:5. doi:10.1186/1475-2840-4-5.
He K, Liu K, Daviglus ML, et al. Magnesium intake and incidence of metabolic syndrome among young adults. Circulation 2006;113(13):1675-1682.
Baihui Xu, Jichao Sun, Xinru Deng, et al. Low serum magnesium level is associated with microalbuminuria in Chinese diabetic patients. International Journal of Endocrinology Article ID- 580685, 2013;2013:pp 6.
Dm Vasudevan. Textbook of Biochemistry 2010;6th edn:420-421.
Yiqing Song, Joann E Manson, Julie E Buring, et al. Dietary magnesium intake in relation to plasma insulin levels and risk of type 2 diabetes in women. Diabetes Care 2004;27(1):59–65.
Martha Rodriguez-Moran, Fernando Guerrero-Romero. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial. Diabetes Care 2003;26(4):1147-1152.
McCarty MF. Magnesium may mediate the favourable impact of whole grains on insulin sensitivity by acting as a mild calcium antagonist. Medical Hypothesis 2005;64(3):619-627.
Mandon B, Siga E, Chabardes D, et al. Insulin stimulates Na+,Cl-,Ca2+, and Mg2+ transports in TAL of mouse nephron: cross potentiation with AVP. American Journal of Physiology 1993;265(3):F361-F369.
Chih-Cheng Hsu, Hsing-Yi Chang, Meng-Chuan Huang, et al. Association between insulin resistance and development of microalbuminuria in type 2 diabetes. Diabetes Care 2011;34:982-987.
Altura BT, Altura BM. Endothelium-dependent relaxation in coronary arteries requires magnesium ions. British Journal of Pharmacology 1987;91(3):449-451.
Ana Rosa Cunha, Bianca Umbelino, Margarida L Correia, et al. Magnesium and vascular changes in hypertension. International Journal of Hypertension Article ID- 754250, 2012;2012:pp 7.
Refbacks
- There are currently no refbacks.